Abstract:Objective To analyze the effects of propranolol combined with methimazole on improving thyroid and liver function in patients with hyperthyroidism.Methods A total of 60 hyperthyroidism patients treated in Department of Endocrinology, Zhengzhou Yihe Hospital from January 2021 to December 2022 were selected and divided into control group (30 cases) and study group (30 cases) according to numerical random allocation method. The effect of medication was compared between the two groups.Results After 10 months of clinical treatment, the clinical efficacy of the two groups was compared and it was found that the total effective rate of the study group (propranolol+methimazole) was significantly better than that of the control group (methimazole), with statistical significance (P<0.05). There was no statistical significance in FT3, FT4 and TSH indexes between the two groups before treatment (P>0.05). However, after 10 months of clinical treatment, FT3 and FT4 indexes of patients in the study group were significantly decreased, and TSH was significantly increased, and was lower than that in the control group, with statistical significance (P<0.05). The indexes of liver function (ALT, AST and TBIL) in the two groups after treatment were statistically different (P<0.05).Conclusion Propranolol combined with methimazole is more effective than single methimazole in the treatment of hyperthyroidism patients, which can significantly improve the thyroid hormone level of patients, reduce liver injury, improve liver function indicators, and reduce adverse reaction rate, and is worthy of clinical promotion.